KCS Dedicated

Inducted to "Hall of Fame" as a 2012 ACS Hero of chemistry for the discovery of Victrelis, the first Hepatitis C virus protease inhibitor approved by FDA Directed discoveries of hepatitis C drugs Victrelis™ (BOCEPREVIR®) that was approved by FDA on May 13th 2011 as the first HCV protease inhibitor and NARLAPREVIR® a second generation HCV protease drug licensed to a Russian company, R-Phama. Spearheaded the discovery of the anti-cancer drug SARASAR®, this drug was approved on the 24th of November 2020 as Zokinvy for the treatment of progeria. Published 104 US granted patents and 136 papers in reputable journals. Received Thomas Alva Edison Patent Award for US patent work on Boceprevir®. Received Emerald Award from Career communication group for leadership excellence in drug discovery. FIRST AFRICAN TO BE GRANTED OVER 100 PATENTS BY US PATENTING AGENCY